Blog

Breast cancer-killing RIG

Immune checkpoint inhibitors — cancer therapies that remove the “brakes” on the adaptive anti-tumor immune response — have had remarkable success in melanoma and lung cancer.


Risk modeling, data integration drive NASA next-gen air travel safety project

Low visibility, bird strikes, incorrect landing approach speed, runway debris, airframe icing, engine fires, unexpected weather and sensor malfunction are but a handful of potential causes of airplane accidents.


Using a mapping technique to reassess prior Alzheimer’s studies finds ‘powerful,’ improved reproducibility

A neural mapping approach that pegs results from more than two dozen previous Alzheimer’s studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.


Study shows magnesium optimizes vitamin D status

A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.


Study identifies novel genetic factors for colorectal cancer risk

A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.


Lindsley receives ASPET award honoring drug discovery research

Craig Lindsley, PhD, a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is being honored by the American Society for Pharmacology and Experimental Therapeutics (ASPET) for his transformative approaches to identifying potential new drugs.


VISE celebrates new home and showcases tech to improve patient care

The Vanderbilt Institute for Surgery and Engineering celebrated its opening of dedicated space in Medical Center North Dec. 12 with a technology showcase of more than two dozen cross-disciplinary collaborations advancing healthcare techniques from the lab to patients.